ESNATS conference-the use of human embryonic stem cells for novel toxicity testing approaches

ATLA Alternatives to Laboratory Animals

Volumn 42, Issue 2, 2014, Pages 97-113

  Rovida, Costanza ^a   Vivier, Manon ^b   Garthoff, Bernward ^c   Hescheler, Jürgen ^d  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c Cluster Biotechnology North Rhine Westphalia   (Germany)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

In vitro testing; Neurotoxicity; Omics technologies; Reproductive toxicity; Stem cells; Toxicokinetics

Indexed keywords

PARACETAMOL; THALIDOMIDE;

BRAIN DEVELOPMENT; CELL DIFFERENTIATION; CONFERENCE PAPER; EMBRYOLOGY; EMBRYONIC STEM CELL; HUMAN; IN VITRO STUDY; LIVER CELL; NERVOUS TISSUE; NEUROTOXICITY; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEOMICS; SKIN; SPECIES COMPARISON; STEM CELL; TOXIC CONCENTRATION; TOXICITY ASSAY; TOXICITY TESTING; TOXICOKINETICS; TRANSCRIPTOMICS; UNITED STATES; ANIMAL; ANIMAL TESTING ALTERNATIVE; ARTICLE; BRAIN; DRUG EFFECT; METHODOLOGY;

ANIMALIA;

ANIMAL TESTING ALTERNATIVES; ANIMALS; BRAIN; EMBRYONIC STEM CELLS; HEPATOCYTES; HUMANS; THALIDOMIDE; TOXICITY TESTS;

EID: 84905113858     PISSN: 02611929     EISSN: 26323559     Source Type: Journal    
DOI: 10.1177/026119291404200203     Document Type: Conference Paper

References (34)

1. ECVAM (undated). Embryonic Stem Cell Test, DBALM Protocol No. 113, Developmental Toxicity, 31pp. Ispra, Italy: European Centre for the Validation of Alternative Methods. Available at: http://ecvam-dbalm.jrc.ec.europa.eu/public-view-doc2.cfm?id=DC5ABDF7AC30F1B7DF7EF27 E87D68AAC7180BB0BC12CB10496CDA74B54630 A05A3291B895581F634 (Accessed 06.01.14).
2. Krug, A.K., Kolde, R., Gaspar, J.A., Rempel, E., Balmer, N.V., Meganathan, K., Vojnits, K., Baquié, M., Waldmann, T., Ensenat-Waser, R., Jagtap, S., Evans, R.M., Julien, S., Peterson, H., Zagoura, D., Kadereit, S., Gerhard, D., Sotiriadou, I., Heke, M., Natarajan, K., Henry, M., Winkler, J., Marchan, R., Stoppini, L., Bosgra, S., Westerhout, J., Verwei, M., Vilo, J., Kortenkamp, A., Hescheler, J., Hothorn, L., Bremer, S., van Thriel, C., Krause, K.H., Hengstler, J.G., Rahnenführer, J., Leist, M. & Sachinidis, A. (2013). Human embryonic stem cell-derived test systems for developmental neurotoxicity: A transcriptomics approach. Archives of Toxicology 87, 123-143.
3. Leist, M., Hartung, T. & Nicotera, P. (2008). The dawning of a new age of toxicology. ALTEX 25, 103-114.
4. Zimmer, B., Kuegler, P.B., Baudis, B., Genewsky, A., Tanavde, V., Koh, W., Tan, B., Waldmann, T., Kadereit, S. & Leist, M. (2011). Coordinated waves of gene expression during neuronal differentiation of embryonic stem cells as basis for novel approaches to developmental neurotoxicity testing. Cell Death & Differentiation 18, 383-395.
5. Kuegler, P.B., Zimmer, B., Waldmann, T., Baudis, B., Ilmjärv, S., Hescheler, J., Gaughwin, P., Brundin, P., Mundy, W., Bal-Price, A.K., Schrattenholz, A., Krause, K.H., van Thriel, C., Rao, M.S., Kadereit, S. & Leist, M. (2010). Markers of murine embryonic and neural stem cells, neurons and astrocytes: Reference points for developmental neurotoxicity testing. ALTEX 27, 17-42.
6. Leist, M., Bremer, S., Brundin, P., Hescheler, J., Kirkeby, A., Krause, K.H., Poerzgen, P., Puceat, M., Schmidt, M., Schrattenholz, A., Zak, N.B. & Hentze, H. (2008). The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy. ALTEX 25, 163-190.
7. Leist, M., Efremova, L. & Karreman, C. (2010). Food for thought... Considerations and guidelines for basic test method descriptions in toxicology. ALTEX 27, 309-317.
8. Leist, M., Hasiwa, N., Daneshian, M. & Hartung, T. (2012). Validation and quality control of replacement alternatives-current status and future challenges. Toxicology Research 1, 8-22.
9. Kadereit, S., Zimmer, B., van Thriel, C., Hengstler, J.G. & Leist, M. (2012). Compound selection for in vitro modeling of developmental neurotoxicity. Frontiers in Bioscience 17, 2442-2460.
10. Godoy, P., Hewitt, N.J., Albrecht, U., Andersen, M.E., Ansari, N., Bhattacharya, S., Bode, J.G., Bolleyn, J., Borner, C., Böttger, J., Braeuning, A., Budinsky, R.A., Burkhardt, B., Cameron, N.R., Camussi, G., Cho, C.S., Choi, Y.J., Rowlands, J.C., Dahmen, U., Damm, G., Dirsch, O., Donato, M.T., Dong, J., Dooley, S., Drasdo, D., Eakins, R., Ferreira, K.S., Fonsato, V., Fraczek, J., Gebhardt, R., Gibson, A., Glanemann, M., Goldring, C.E., Gómez-Lechón, M.J., Groothuis, G.M., Gustavsson, L., Guyot, C., Hallifax, D., Hammad, S., Hayward, A., Häussinger, D., Hellerbrand, C., Hewitt, P., Hoehme, S., Holzhütter, H.G., Houston, J.B., Hrach, J., Ito, K., Jaeschke, H., Keitel, V., Kelm, J.M., Park, K.B., Kordes, C., Kullak-Ublick, G.A., LeCluyse, E.L., Lu, P., Luebke-Wheeler, J., Lutz, A., Maltman, D.J., Matz-Soja, M., McMullen, P., Merfort, I., Messner, S., Meyer, C., Mwinyi, J., Naisbitt, D.J., Nussler, A.K., Olinga, P., Pampaloni, F., Pi, J., Pluta, L., Przyborski, S.A., Ramachandran, A., Rogiers, V., Rowe, C., Schelcher, C., Schmich, K., Schwarz, M., Singh, B., Stelzer, E.H., Stieger, B., Stöber, R., Sugiyama, Y., Tetta, C., Thasler, W.E., Vanhaecke, T., Vinken, M., Weiss, T.S., Widera, A., Woods, C.G., Xu, J.J., Yarborough, K.M. & Hengstler, J.G. (2013). Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Archives of Toxicology 87, 1315-1530.
11. Zellmer, S., Schmidt-Heck, W., Godoy, P., Weng, H., Meyer, C., Lehmann, T., Sparna, T., Schormann, W., Hammad, S., Kreutz, C., Timmer, J., von Weiz-säcker, F., Thürmann, P.A., Merfort, I., Guthke, R., Dooley, S., Hengstler, J.G. & Gebhardt, R. (2010). Transcription factors ETF, E2F, and SP-1 are involved in cytokine-independent proliferation of murine hepatocytes. Hepatology 52, 2127-2136.
12. Godoy, P., Hengstler, J.G., Ilkavets, I., Meyer, C., Bachmann, A., Müller, A., Tuschl, G., Mueller, S.O. & Dooley, S. (2009). Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor betainduced apoptosis. Hepatology 49, 2031-2043.
13. Adler, S., Basketter, D., Creton, S., Pelkonen, O., van Benthem, J., Zuang, V., Andersen, K.E., Angers-Loustau, A., Aptula, A., Bal-Price, A., Benfenati, E., Bernauer, U., Bessems, J., Bois, F.Y., Boobis, A., Brandon, E., Bremer, S., Broschard, T., Casati, S., Coecke, S., Corvi, R., Cronin, M., Daston, G., Dekant, W., Felter, S., Grignard, E., Gundert-Remy, U., Heinonen, T., Kimber, I., Kleinjans, J., Komulainen, H., Kreiling, R., Kreysa, J., Leite, S.B., Loizou, G., Maxwell, G., Mazzatorta, P., Munn, S., Pfuhler, S., Phrakonkham, P., Piersma, A., Poth, A., Prieto, P., Repetto, G., Rogiers, V., Schoeters, G., Schwarz, M., Serafimova, R., Tähti, H., Testai, E., van Delft, J., van Loveren, H., Vinken, M., Worth, A. & Zaldivar, J.M. (2010). Alternative (non-animal) methods for cosmetics testing: Current status and future prospects. Archives of Toxicology 85, 367-485.
14. Hartung, T., Blaauboer, B.J., Bosgra, S., Carney, E., Coenen, J., Conolly, R.B., Corsini, E., Green, S., Faustman, E.M., Gaspari, A., Hayashi, M., Wallace Hayes, A., Hengstler, J.G., Knudsen, L.E., Knud-sen, T.B., McKim, J.M., Pfaller, W. & Roggen, E.L. (2011). An expert consortium review of the EC-commissioned report "Alternative (non-animal) methods for cosmetics testing: Current status and future prospects-2010". ALTEX 28, 183-209.
15. Verwei, M., van Burgsteden, J.A., Krul, C.A., van de Sandt, J.J. & Freidig, A.P. (2006). Prediction of in vivo embryotoxic effect levels with a combination of in vitro studies and PBPK modelling. Toxicology Letters 165, 79-87.
16. Piersma, A.H., Bosgra, S., van Duursen, M.B., Herm-sen, S.A., Jonker, L.R., Kroese, E.D., van der Linden, S.C., Man, H., Roelofs, M.J., Schulpen, S.H., Schwarz, M., Uibel, F., van Vugt-Lussenburg, B.M., Westerhout, J., Wolterbeek, A.P. & van der Burg, B. (2013). Evaluation of an alternative in vitro test battery for detecting reproductive toxicants. Repro-ductive Toxicology 38, 53-64.
17. Preynat-Seauve, O., Suter, D.M., Tirefort, D., Turchi, L., Virolle, T., Chneiweiss, H., Foti, M., Lobrinus, J.A., Stoppini, L., Feki, A., Dubois-Dauphin, M. & Krause, K.H. (2009). Development of human nervous tissue upon differentiation of embryonic stem cells in three-dimensional culture. Stem Cells 27, 509-520.
18. Lancaster, M.A., Renner, M., Martin, C.A., Wenzel, D., Bicknell, L.S., Hurles, M.E., Homfray, T., Penninger, J.M., Jackson, A.P. & Knoblich, J.A. (2013). Cerebral organoids model human brain development and microcephaly. Nature, London 501, 373-379.
19. Nayernia, Z., Turchi, L., Cosset, E., Peterson, H., Dutoit, V., Dietrich, P.Y., Tirefort, D., Chneiweiss, H., Lobrinus, J.A., Krause, K.H., Virolle, T. & Preynat-Seauve, O. (2013). The relationship between brain tumor cell invasion of engineered neural tissues and in vivo features of glioblastoma. Biomaterials 34, 8279-8290.
20. Meganathan, K., Jagtap, S., Wagh, V., Winkler, J., Gaspar, J.A., Hildebrand, D., Trusch, M., Lehmann, K. Hescheler, J., Schlüter, H. & Sach inidis, A. (2012). Identification of thalidomide-specific transcriptomics and proteomics signatures during differentiation of human embryonic stem cells. PLoS One 7, e44228.
21. Robinson, J.F., Verhoef, A., Pennings, J.L., Pronk, T.E. & Piersma, A.H. (2012). A comparison of gene expression responses in rat whole embryo culture and in vivo: Time-dependent retinoic acid-induced teratogenic response. Toxicological Sciences 126, 242-254.
22. Balls, M., Blaauboer, B.J., Fentem, J.H., Bruner, L., Combes, R.D., Ekwall, B., Fielder, R.J., Guillouzo, A., Lewis, R.W., Lovell, D.P., Reinhardt, C.A., Repetto, G., Sladowski, D., Spielmann, H. & Zucco, F. (1995). Practical aspects of the validation of toxicity test procedures. The report and recommendations of ECVAM workshop 5. ATLA 23, 129-147.
23. Curren, R.D., Southee, J.A., Spielmann, H., Liebsch, M., Fentem, J.H. & Balls, M. (1995). The role of prevalidation in the development, validation and acceptance of alternative methods. ECVAM prevalidation task force report 1. ATLA 23, 211-217.
24. Hartung, T., Bremer, S., Casati, S., Coecke, S., Corvi, R., Fortaner, S., Gribaldo, L., Halder, M., Hoffmann, S., Roi, A.J., Prieto, P., Sabbioni, E., Scott, L., Worth, A. & Zuang, V. (2004). A modular approach to the ECVAM principles on test validity. ATLA 32, 467-472.
25. Moors, M., Rockel, T.D., Abel, J., Cline, J.E., Gassmann, K., Schreiber, T., Schuwald, J., Wein-mann, N. & Fritsche, E. (2009). Human neuro-spheres as three-dimensional cellular systems for developmental neurotoxicity testing. Environ-mental Health Perspectives 117, 1131-1138.
26. Gassmann, K., Abel, J., Bothe, H., Haarmann-Stemmann, T., Merk, H.F., Quasthoff, K.N., Rockel, T.D., Schreiber, T. & Fritsche, E. (2010). Speciesspecific differential AhR expression protects human neural progenitor cells against developmental neurotoxicity of PAHs. Environmental Health Per-spectives 118, 1571-1577.
27. Gassmann, K., Baumann, J., Giersiefer, S., Schu-wald, J., Schreiber, T., Merk, H.F. & Fritsche, E. (2012). Automated neurosphere sorting and plating by the COPAS large particle sorter is a suitable method for high-throughput 3D in vitro applications. Toxicology in Vitro 26, 993-1000.
28. EPA (2003). A Framework for a Computational Toxicology Research Program, 38pp. Washington, DC, USA: US Environmental Protection Agency. Available at: www.epa.gov/ncct/download-files/basic-information/comptoxframework06-02-04.pdf (Accessed 06.01.14).
29. National Research Council (2007). Toxicity Testing in the 21st Century: A Vision and a Strategy, 216pp. Washington, DC, USA: National Academies Press.
30. Rotroff, D.M., Wetmore, B.A., Dix, D.J., Ferguson, S.S., Clewell, H.J., Houck, K.A., LeCluyse, E.L., Andersen, M.E., Judson, R.S., Smith, C.M., Soch-aski, M.A., Kavlock, R.J., Boellmann, F., Martin, M.T., Reif, D.M., Wambaugh, J.F. & Thomas, R.S. (2010). Incorporating human dosimetry and exposure into high-throughput in vitro toxicity screening. Toxicological Sciences 117, 348-358.
31. Sipes, N.S., Martin, M.T., Reif, D.M., Kleinstreuer, N.C., Judson, R.S., Singh, A.V., Chandler, K.J., Dix, D.J., Kavlock, R.J. & Knudsen, T.B. (2011). Predictive models of prenatal developmental toxicity from ToxCast high-throughput screening data. Toxicological Sciences 124, 109-127.
32. Kleinstreuer, N., Dix, D., Rountree, M., Baker, N., Sipes, N., Reif, D., Spencer, R. & Knudsen, T. (2013). A computational model predicting disruption of blood vessel development. PLoS Comput-ational Biology 9, 1-20.
33. Sansone, S.A., Rocca-Serra, P., Field, D., Maguire, E., Taylor, C., Hofmann, O., Fang, H., Neumann, S., Tong, W., Amaral-Zettler, L., Begley, K., Booth, T., Bougueleret, L., Burns, G., Chapman, B., Clark, T., Coleman, L.A., Copeland, J., Das, S., de Daruvar, A., de Matos, P., Dix, I., Edmunds, S., Evelo, C.T., Forster, M.J., Gaudet, P., Gilbert, J., Goble, C., Griffin, J.L., Jacob, D., Kleinjans, J., Harland, L., Haug, K., Hermjakob, H., Ho Sui, S.J., Laederach, A., Liang, S., Marshall, S., McGrath, A., Merrill, E., Reilly, D., Roux, M., Shamu, C.E., Shang, C.A., Steinbeck, C., Trefethen, A., Williams-Jones, B., Wolstencroft, K., Xenarios, I. & Hide, W. (2012). Toward interoperable bioscience data. Nature Genetics 44, 121-126.
34. Caiment, F., Tsamou, M., Jennen, D. & Kleinjans, J. (2014). Assessing compound carcinogenicity in vitro using connectivity mapping. Carcinogenesis 35, 201-207.